According to NanoString Technologies's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.0311858. At the end of 2023 the company had a P/S ratio of 0.5033.
Year | P/S ratio | Change |
---|---|---|
2023 | 0.5033 | -82.77% |
2022 | 2.92 | -78.01% |
2021 | 13.3 | -47.1% |
2020 | 25.1 | 212.37% |
2019 | 8.04 | 87.23% |
2018 | 4.30 | 160.29% |
2017 | 1.65 | -69.53% |
2016 | 5.42 | 17.89% |
2015 | 4.59 | -14.1% |
2014 | 5.35 | -33.37% |
2013 | 8.03 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
Thermo Fisher Scientific TMO | 4.87 | 15,529.52% | ๐บ๐ธ USA |
Agilent Technologies A | 5.85 | 18,673.19% | ๐บ๐ธ USA |
Illumina ILMN | 4.18 | 13,311.78% | ๐บ๐ธ USA |
PerkinElmer
PKI | 4.31 | 13,706.25% | ๐บ๐ธ USA |
Pacific Biosciences
PACB | 1.87 | 5,898.85% | ๐บ๐ธ USA |
Luminex LMNX | N/A | N/A | ๐บ๐ธ USA |
Bio-Rad Laboratories BIO | 3.19 | 10,135.56% | ๐บ๐ธ USA |